Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Illinois at Chicago
Age
18–60
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with the following diseases:
* Acute myeloid or lymphoblastic leukemia in first complete remission if poor prognosis documented by failure to response after initial induction chemotherapy, or cytogenetic, or molecular studies.
* Acute leukemia in greater/equal second remission, or partial remission after chemotherapy.
* High grade non Hodgkin's or Hodgkin's lymphoma with marrow involvement resistant/ relapsed after second line therapy including high dose chemotherapy and autologous SCT.
* CML in advanced or blastic phase.
* Plasma cell leukemia.
Age 18-60 years.
Karnofsky performance status of 70
Adequate cardiac and pulmonary function. Patients with decreased LVEF less than/equal to 40% or DLCO less than/equal to 50% of predicted will require clearance from cardiology or pulmonary services, respectively, prior to enrollment on this protocol.
Serum creatinine less than/equal to 1.5 mg/dL or Creatinine Clearance greater than/equal to 50 ml/min .
Serum bilirubin 2.0 mg/dl, SGPT less than/equal to 3 times the upper limit of normal
You may not be if
Life expectancy is severely limited by concomitant illness.
Evidence of chronic active hepatitis or cirrhosis
HIV-positive
Patient is pregnant
Patient or guardian is not able to sign informed consent.
